Raj Bhandari

830 total citations
13 papers, 593 citations indexed

About

Raj Bhandari is a scholar working on Oncology, Pharmacology and Genetics. According to data from OpenAlex, Raj Bhandari has authored 13 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pharmacology and 3 papers in Genetics. Recurrent topics in Raj Bhandari's work include Pharmacological Effects of Natural Compounds (3 papers), Colorectal Cancer Screening and Detection (3 papers) and Inflammatory Bowel Disease (3 papers). Raj Bhandari is often cited by papers focused on Pharmacological Effects of Natural Compounds (3 papers), Colorectal Cancer Screening and Detection (3 papers) and Inflammatory Bowel Disease (3 papers). Raj Bhandari collaborates with scholars based in United States, Spain and Netherlands. Raj Bhandari's co-authors include Douglas K. Rex, Daniel Lorch, David Bernstein, Michael O. Meyers, Frank Schippers, Charles F. Barish, Cynthia Schaeffer, K. Peter Etzkorn, David Bernstein and Shelby Sullivan and has published in prestigious journals such as Gastroenterology, Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Raj Bhandari

12 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raj Bhandari United States	8	278	183	158	148	83	13	593
Michael E. Johnson United States	12	48 0.2×	147 0.8×	72 0.5×	47 0.3×	19 0.2×	14	462
Steve Kunkel United States	8	82 0.3×	167 0.9×	9 0.1×	47 0.3×	21 0.3×	16	415
Heidi Robertshaw United Kingdom	9	53 0.2×	94 0.5×	14 0.1×	35 0.2×	4 0.0×	17	336
Ewelina Perdas Poland	11	39 0.1×	109 0.6×	17 0.1×	14 0.1×	7 0.1×	21	405
Heinrich Fürst Germany	9	99 0.4×	197 1.1×	14 0.1×	53 0.4×	3 0.0×	11	552
M. H. Carstensen Germany	9	83 0.3×	132 0.7×	9 0.1×	19 0.1×	13 0.2×	23	424
Estefanía Batalla-Solís Spain	10	17 0.1×	33 0.2×	75 0.5×	106 0.7×	21 0.3×	10	457
Elisabet Tina Sweden	12	13 0.0×	71 0.4×	26 0.2×	64 0.4×	10 0.1×	23	353
Isabel S. Jerchel Netherlands	8	25 0.1×	41 0.2×	17 0.1×	41 0.3×	6 0.1×	12	362
Haiyuan Liu China	13	16 0.1×	63 0.3×	16 0.1×	41 0.3×	11 0.1×	39	404

Countries citing papers authored by Raj Bhandari

Since Specialization

Citations

This map shows the geographic impact of Raj Bhandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raj Bhandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raj Bhandari more than expected).

Fields of papers citing papers by Raj Bhandari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raj Bhandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raj Bhandari. The network helps show where Raj Bhandari may publish in the future.

Co-authorship network of co-authors of Raj Bhandari

This figure shows the co-authorship network connecting the top 25 collaborators of Raj Bhandari. A scholar is included among the top collaborators of Raj Bhandari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raj Bhandari. Raj Bhandari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Jadhav, Kavita, et al.. (2023). Analysis and Design of RCC Retaining Wall to Overcome Landslide. International Journal for Research in Applied Science and Engineering Technology. 11(4). 3972–3978.

Bhandari, Raj, Michael J. Goldstein, Daniel S. Mishkin, et al.. (2023). Comparison of a Novel, Flavor-optimized, Polyethylene Glycol and Sulfate Bowel Preparation With Oral Sulfate Solution in Adults Undergoing Colonoscopy. Journal of Clinical Gastroenterology. 57(9). 920–927. 3 indexed citations

Sandborn, William J., Larry Mattheakis, Nishit B. Modi, et al.. (2021). PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis. Gastroenterology. 161(6). 1853–1864.e10. 28 indexed citations

Rex, Douglas K., Raj Bhandari, Daniel Lorch, et al.. (2020). Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial. Digestive and Liver Disease. 53(1). 94–101. 107 indexed citations

Palma, Jack A. Di, et al.. (2020). A Safety and Efficacy Comparison of a New Sulfate-Based Tablet Bowel Preparation Versus a PEG and Ascorbate Comparator in Adult Subjects Undergoing Colonoscopy. The American Journal of Gastroenterology. 116(2). 319–328. 23 indexed citations

DiPalma, Jack A., et al.. (2020). S0519 Comparison of Safety and Efficacy of a New Oral Sulfate-Based Tablet Bowel Preparation Compared to Split Dose PEG-EA. The American Journal of Gastroenterology. 115(1). S259–S259. 1 indexed citations

Sandborn, William J., Deanna D. Nguyen, David T. Beattie, et al.. (2020). Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme. Journal of Crohn s and Colitis. 14(9). 1202–1213. 65 indexed citations

Sandborn, William J., Raj Bhandari, Jonathan A. Leighton, et al.. (2019). P041 THE GUT-SELECTIVE, ORALLY ADMINISTERED, PAN-JAK INHIBITOR TD-1473 DEMONSTRATES FAVORABLE SAFETY, TOLERABILITY, PHARMACOKINETIC, AND SIGNAL FOR CLINICAL ACTIVITY IN SUBJECTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS. Inflammatory Bowel Diseases. 25(Supplement_1). S20–S21. 3 indexed citations

Sandborn, William J., Raj Bhandari, Jonathan A. Leighton, et al.. (2019). P041 THE GUT-SELECTIVE, ORALLY ADMINISTERED, PAN-JAK INHIBITOR TD-1473 DEMONSTRATES FAVORABLE SAFETY, TOLERABILITY, PHARMACOKINETIC, AND SIGNAL FOR CLINICAL ACTIVITY IN SUBJECTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS. Gastroenterology. 156(3). S29–S30. 12 indexed citations

10.

Sandborn, William J., Marc Ferrante, Raj Bhandari, et al.. (2019). P033 EFFICACY OF MIRIKIZUMAB ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY. Gastroenterology. 156(3). S23–S23. 1 indexed citations

11.

Rex, Douglas K., Raj Bhandari, Taddese Desta, et al.. (2018). A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointestinal Endoscopy. 88(3). 427–437.e6. 196 indexed citations

12.

Berry, Scott, Charles F. Barish, Raj Bhandari, et al.. (2013). Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study. BMC Gastroenterology. 13(1). 106–106. 20 indexed citations

13.

Ratziu, Vlad, Muhammad Y. Sheikh, Arun J. Sanyal, et al.. (2011). A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of GS-9450 in Subjects With Nonalcoholic Steatohepatitis. Hepatology. 55(2). 419–428. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact